These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1898981)

  • 1. Change of dosing regimen for malaria prophylaxis with mefloquine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Feb; 40(4):72-3. PubMed ID: 1898981
    [No Abstract]   [Full Text] [Related]  

  • 2. From the Centers for Disease Control. Change of dosing regimen for malaria prophylaxis with mefloquine.
    JAMA; 1991 Feb; 265(7):849. PubMed ID: 1992177
    [No Abstract]   [Full Text] [Related]  

  • 3. [Failure of prevention of malaria by mefloquine in West Africa].
    Bricaire F; Gay F; Caumes E; Datry A; Bustos D; Félix H; Paris L; Danis M; Gentilini M
    Ann Med Interne (Paris); 1990; 141(6):512-4. PubMed ID: 2285203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. Need for a better dosing regimen.
    Lobel HO; Bernard KW; Williams SL; Hightower AW; Patchen LC; Campbell CC
    JAMA; 1991 Jan; 265(3):361-4. PubMed ID: 1984534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mefloquine for malaria.
    Med Lett Drugs Ther; 1990 Feb; 31(811):13-4. PubMed ID: 2405246
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmodium falciparum malaria associated with mefloquine failure in Gambia.
    Callen EC; Church CO
    Pharmacotherapy; 2006 Oct; 26(10):1526-8. PubMed ID: 16999663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
    Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria prevention in travelers.
    Juckett G
    Am Fam Physician; 1999 May; 59(9):2523-30, 2535-6. PubMed ID: 10323359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline.
    Schwartz E; Regev-Yochay G
    Clin Infect Dis; 1999 Dec; 29(6):1502-6. PubMed ID: 10585803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proguanil daily or chlorproguanil twice weekly are efficacious against falciparum malaria in a holoendemic area of Tanzania.
    Rooth I; Sinani HM; Björkman A
    J Trop Med Hyg; 1991 Feb; 94(1):45-9. PubMed ID: 1995934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinine resistant falciparum malaria treated with mefloquine.
    Harinasuta T; Bunnag D; Lasserre R
    Southeast Asian J Trop Med Public Health; 1990 Dec; 21(4):552-7. PubMed ID: 2098915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearing the air on malaria.
    Wittes R
    CMAJ; 1991 Mar; 144(6):661-3. PubMed ID: 1998925
    [No Abstract]   [Full Text] [Related]  

  • 13. Is mefloquine prophylaxis ineffective for short-term travellers?
    Wetsteyn JC; Cobelens FG; Kager PA; Eggelte TA
    Lancet; 1995 Aug; 346(8974):574. PubMed ID: 7658795
    [No Abstract]   [Full Text] [Related]  

  • 14. Case 4-2009: a pregnant woman with fever after a trip to Africa.
    Itskowitz M
    N Engl J Med; 2009 Jun; 360(23):2481; author reply 2482. PubMed ID: 19494230
    [No Abstract]   [Full Text] [Related]  

  • 15. [Malaria in Norway--diagnosis, treatment and prevention].
    Myrvang B
    Tidsskr Nor Laegeforen; 2000 May; 120(14):1648-52. PubMed ID: 10901075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artesunate with mefloquine at various intervals for non-severe Plasmodium falciparum malaria.
    Hung le Q; de Vries PJ; Binh TQ; Giao PT; Nam NV; Holman R; Kager PA
    Am J Trop Med Hyg; 2004 Aug; 71(2):160-6. PubMed ID: 15306704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mefloquine resistance in Plasmodium falciparum malaria].
    Garavelli PL
    Recenti Prog Med; 2003; 94(7-8):343. PubMed ID: 12868243
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol).
    Pearlman EJ; Doberstyn EB; Sudsok S; Thiemanun W; Kennedy RS; Canfield CJ
    Am J Trop Med Hyg; 1980 Nov; 29(6):1131-7. PubMed ID: 7004214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
    Silachamroon U; Krudsood S; Thanachartwet W; Tangpukdee N; Leowattana W; Chalermrut K; Srivilairit S; Wilaiaratana P; Thimasarn K; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):591-6. PubMed ID: 16124422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Sagara I; Diallo A; Kone M; Coulibaly M; Diawara SI; Guindo O; Maiga H; Niambele MB; Sissoko M; Dicko A; Djimde A; Doumbo OK
    Am J Trop Med Hyg; 2008 Nov; 79(5):655-61. PubMed ID: 18981499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.